AC8
Click for more information
0.00% 4.0¢ auscann group holdings ltd

Ann: AusCann Releases Hard-shell Capsules to Clinical Evaluation, page-13

  1. seahunt
    4,331 Posts.
    lightbulb Created with Sketch. 452
    clock Created with Sketch.
    18/12/19
    11:12
    Post #: 42026117
    Its not a real clinical trail its ,commercially focused, short clinical evaluation.
    So it still a while off
    Congrats to those who bought under 20 cents
    This is the pop you needed.
    Hope its not going to be a dead cat bounce
    AC8 Price at posting: 22.0¢ Sentiment: Sell Disclosure: Not Held
    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

GBR Great Boulder hits fresh gold finds to the north of Mulga Bill in Meekatharra, WA
right-arrow Created with Sketch.
EBR EBR Systems’ heart pacing device on-target to reach the US market
right-arrow Created with Sketch.
NEWS Is the ASX getting its groove back? Here's 5 IPOs in September to watch
right-arrow Created with Sketch.
RBD Restaurant Brands posts record sales in half year report for FY24
right-arrow Created with Sketch.
STX Strike hits "significant" 28m of net gas pay downhole Australia's deepest ever gas well; extends system east
right-arrow Created with Sketch.
GED Golden Deeps sniffs 80-metre-long copper and zinc sulphide zone at NSW's Havilah
right-arrow Created with Sketch.
watchlist Created with Sketch. Add AC8 (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.